Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE: Alteplase in Ischemic Stroke 4.5-24 Hours
NCT04879615Phase 3Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2021
- Primary completion
- Jun 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jun 2021; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04879615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04879615.